iTeos Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$1.04 | -$1.04 | -$1.04 |
| Q2 2024 | 1 | -$1.17 | -$1.17 | -$1.17 |
| Q3 2024 | 3 | -$1.32 | -$0.84 | -$1.05 |
| Q1 2025 | 3 | -$1.51 | -$0.91 | -$1.12 |
| Q2 2025 | 2 | -$1.19 | -$1.19 | -$1.19 |
| Q3 2025 | 2 | -$1.16 | -$1.16 | -$1.16 |
| Q4 2025 | 2 | -$1.07 | -$1.07 | -$1.07 |
| Q1 2026 | 1 | -$1.29 | -$1.29 | -$1.29 |
| Q2 2026 | 1 | -$1.31 | -$1.31 | -$1.31 |
| Q3 2026 | 1 | -$1.32 | -$1.32 | -$1.32 |
| Q4 2026 | 1 | -$1.34 | -$1.34 | -$1.34 |
| Q1 2027 | 1 | -$1.34 | -$1.34 | -$1.34 |
| Q2 2027 | 1 | -$1.24 | -$1.24 | -$1.24 |
| Q3 2027 | 1 | -$1.10 | -$1.10 | -$1.10 |
| Q4 2027 | 1 | -$0.87 | -$0.87 | -$0.87 |
iTeos Therapeutics, Inc. Earnings Date And Information
iTeos Therapeutics, Inc. last posted its earnings results on Thursday, August 8th, 2024. The company reported $-0.18 earnings per share for the quarter, topping analysts' consensus estimates of $-1.04 by $0.86. The company had revenue of 0 for the quarter and had revenue of 12.60 M for the year. iTeos Therapeutics, Inc. has generated $-3 earnings per share over the last year ($-3.15 diluted earnings per share) and currently has a price-to-earnings ratio of -2.96. iTeos Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based on prior year's report dates.
iTeos Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$1.05 | $800,000 | $0 | ||
| 08/08/2024 | Q2 2024 | -$1.04 | -$0.18 | 0.86 | $1.00 M | $35.00 M |
| 05/10/2024 | Q1 2024 | -$1.02 | -$1.07 | -0.05 | $0 | |
| 03/06/2024 | Q4 2023 | -$1.03 | -$0.85 | 0.18 | $-11,303,000 | |
| 11/07/2023 | Q3 2023 | -$1.20 | -$0.90 | 0.3 | $0 | |
| 08/08/2023 | Q2 2023 | -$1.03 | -$0.96 | 0.07 | $0 | |
| 05/10/2023 | Q1 2023 | -$0.99 | -$0.44 | 0.55 | $12.60 M | |
| 03/15/2023 | Q4 2022 | $0.42 | $0.57 | 0.15 | $53.91 M | |
| 11/10/2022 | Q3 2022 | $0.10 | $0.03 | -0.07 | $41.64 M | $19.49 M |
| 08/10/2022 | Q2 2022 | $1.20 | $0.15 | -1.05 | $85.56 M | $41.72 M |
| 05/12/2022 | Q1 2022 | $0.80 | $1.82 | 1.02 | $152.52 M | |
| 03/23/2022 | Q4 2021 | $1.29 | $5.26 | 3.97 | $240.50 M | |
| 11/10/2021 | Q3 2021 | $4.95 | $1.98 | -2.97 | $6.50 M | $104.27 M |
| 08/11/2021 | Q2 2021 | -$0.75 | $3.91 M | $0 | ||
| 05/13/2021 | Q1 2021 | -$0.48 | -$0.39 | 0.09 | $0 | |
| 03/24/2021 | Q4 2020 | -$0.42 | -$0.61 | -0.19 | $0 | |
| 11/12/2020 | Q3 2020 | -$0.36 | -$0.44 | -0.08 | $0 | |
| 09/01/2020 | Q2 2020 | -$0.47 | -$0.23 | 0.24 | $0 | |
| 03/30/2020 | Q1 2020 | -$0.17 | $0 | |||
| 12/30/2019 | Q4 2019 | -$0.54 | $0 |
iTeos Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is iTeos Therapeutics, Inc.'s earnings date?
iTeos Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based off last year's report dates.
-
Did iTeos Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, iTeos Therapeutics, Inc. (:ITOS) reported $-0.18 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.04 by $0.86.
-
How can I listen to iTeos Therapeutics, Inc.'s earnings conference call?
The conference call for iTeos Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read iTeos Therapeutics, Inc.'s conference call transcript?
The conference call transcript for iTeos Therapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does iTeos Therapeutics, Inc. generate each year?
iTeos Therapeutics, Inc. (:ITOS) has a recorded annual revenue of $12.60 M.
-
How much profit does iTeos Therapeutics, Inc. generate each year?
iTeos Therapeutics, Inc. (:ITOS) has a recorded net income of $12.60 M. iTeos Therapeutics, Inc. has generated $-3.15 earnings per share over the last four quarters.
-
What is iTeos Therapeutics, Inc.'s price-to-earnings ratio?
iTeos Therapeutics, Inc. (:ITOS) has a price-to-earnings ratio of -2.96 and price/earnings-to-growth ratio is 0.59.
